![SYSMEX_17760_Publicati6on_list_OSNA_CC_EN](/fileadmin/_processed_/5/5/csm_OSNA_CRC_Publication_Spotlight_a93a8b5445.png)
Lymph node status is a critical factor to predict outcomes and identify patients eligible for chemotherapy. Although histopathology based on H&E is a standard method for lymph node analysis, 30 % of patients diagnosed with negative lymph nodes develop recurrences, likely due to undetected metastases.
File type:
pdf
File size:
156 KB
Release:
26-02-21